Raaj Medisafe India Ltd.
Snapshot View

28.55 ▼0%

08 February 2023, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Medical Equipment/Supplies/Accessories Compare with Industry peers
Website http://www.raajmedisafeindia.com
Market Cap 31.23 Cr.
Enterprise Value(EV) 46.85 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 2.63 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 10.84 Trailing Twelve Months Ending 2022-09
Industry PE 55.60 Trailing Twelve Months Ending 2022-09
Book Value / Share 5.36 Trailing Twelve Months Ending 2022-09
Price to Book Value 5.32 Calculated using Price: 28.55
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.09 Cr. 10,937,612 Shares
FaceValue 10
Company Profile
The company deals in wide range of personal and hospital hygiene related products like disposable bed sheets, pillow covers, stretcher sheets, under pads, sanitary napkins, panty liners, baby diapers & adult diapers, etc.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
-6.24%
1 Month
-13.75%
3 Month
-15.91%
6 Month
-4.67%
1 Year
-14.14%
2 Year
+153.78%
5 Year
+230.44%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 115.41
Return on Capital Employed (%) -20.12 -24.25 -13.98 -8.33 -21.00 -24.82 16.30 27.03 28.33
Return on Assets (%) -21.30 -33.33 -22.40 -15.08 -26.04 -30.95 -3.09 15.23 16.63

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds -1 -3 -4 -5 -6 -8 -1 1 4 6
Non Curr. Liab. 4 7 7 8 8 10 8 9 6 8
Curr. Liab. 0 0 2 3 3 3 7 7 10 10
Minority Int.
Equity & Liab. 3 4 5 6 5 5 14 17 20 24
Non Curr. Assets 2 3 4 4 3 3 7 9 10 11
Curr. Assets 1 1 2 2 2 2 6 7 10 14
Misc. Exp. not W/O
Total Assets 3 4 5 6 5 5 14 17 20 24

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 2 4 4 5 22 32 35 36
Other Income 0 0 0 0 0 0 0 0 0
Total Income 0 0 2 4 4 5 22 32 35 36
Total Expenditure 0 -1 -2 -4 -4 -6 -20 -28 -30 -32
PBIDT 0 -1 0 0 0 -1 2 4 5 5
Interest 0 0 -1 -1 -1 -1 -1 -1 -1 -1
Depreciation 0 0 0 0 0 0 -1 -1 -1 -1
Taxation 0 0 -1 0
Exceptional Items 0 0 0 0 0 0 0 0
PAT 0 -1 -1 -1 -1 -2 0 2 3 3
Adjusted EPS -1 -2 -2 -2 -3 -3 -1 2 3 3

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 0 -1 0 0 0 0 -1 -1 2 2
Cash Fr. Inv. 0 -2 -1 -1 0 0 0 -3 -1
Cash Fr. Finan. 0 1 3 0 1 0 1 1 1 -1
Net Change 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 44.85 44.85 44.85 73.45 73.45 73.45 73.45 73.45 73.45
Public 55.15 55.15 55.15 26.55 26.55 26.55 26.55 26.55 26.55
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 06 Feb 2023
Update on board meeting
The Board Meeting to be held on 08/02/2023 has been revised to 13/02/2023 The Board Meeting to be held on 08/02/2023 has been revised to 13/02/2023
Fri, 03 Feb 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we furnish below the information regarding loss of 1400 (One Thousand Four hundred) shares received from the Shareholder as per Annexure attached hereto. As required under SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January25 2022 the Company shall issue Letter of Confirmation to the Shareholder after compliance of required Formalities.
Tue, 31 Jan 2023
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December 31 2022
RAAJ MEDISAFE INDIA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2023 inter alia to consider and approve 1. To take note of Minutes of previous Board meetings and committees. 2.To approve Unaudited Financial Results for the quarter ended 31st Dec. 2022. 3. To take note of the Related Party Transactions entered during the quarter ended 31st Dec. 2022. 4. To adopt Reconciliation of Share Capital Audit for the quarter ended 31st Dec. 2022.5. To take on record: (a).Statement of Investors complaints and Shareholding Pattern for the quarter ended 31st Dec. 2022(b)Corporate Governance Report for the quarter ended 31st Dec. 2022 (c). Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st Dec. 2022.(d). Compliance Certificate pursuant to provisions of Regulation 3(5) and 3(6) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 for the Quarter ended 31st Dec. 2022.Any other item may be taken up.

Technical Scans View Details >>

Wed, 08 Feb 2023
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.45 -0.6%
Cipla Ltd. 83,886.47 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,510.00 +0.5%
Divi's Laboratories Ltd. 74,340.49 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. 52,675.65 1,545.10 -0.7%
Zydus Lifesciences Ltd. 47,993.66 473.65 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 473.65 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 473.65 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 473.65 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.65 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 473.65 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 473.65 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.45 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.05 -1.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,510.00 +0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,813.30 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,402.10 +0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.10 -0.7%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 473.65 -0.1%

FAQ's On Raaj Medisafe India Ltd.

What is Raaj Medisafe India share price?

Can I buy Raaj Medisafe India shares now?

What is the Market Cap of Raaj Medisafe India?

What are the key metrics to analyse Raaj Medisafe India?

What is the 52 Week High and Low of Raaj Medisafe India?